Terumo (OTCMKTS:TRUMY) Shares Gap Up - What's Next?

Key Points

• Terumo Corp. (OTCMKTS:TRUMY) shares opened at $19.60 after closing at $18.87, reflecting a significant gap up in trading.
• The company reported earnings of $0.20 per share for the last quarter, surpassing analysts' expectations of $0.17, despite revenue falling short at $1.76 billion compared to an estimate of $1.80 billion.
• Terumo holds a market cap of $27.92 billion and maintains a healthy financial standing with a debt-to-equity ratio of 0.12.

Terumo Corp. (OTCMKTS:TRUMY - Get Free Report) shares gapped up before the market opened on Tuesday . The stock had previously closed at $18.87, but opened at $19.60. Terumo shares last traded at $18.86, with a volume of 1,673 shares changing hands.

Terumo Trading Down 0.1%

The company has a current ratio of 3.00, a quick ratio of 1.78 and a debt-to-equity ratio of 0.12. The company has a 50-day simple moving average of $17.58 and a 200 day simple moving average of $18.22. The firm has a market cap of $27.92 billion, a PE ratio of 33.08 and a beta of 0.80.

Terumo (OTCMKTS:TRUMY - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.17 by $0.03. Terumo had a return on equity of 9.30% and a net margin of 12.09%.The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.80 billion.

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.